Ian VanOeveren
Ian VanOeveren is a CMC consultant with over 11 years of experience in analytical sciences. Much of his career has been focused on small-molecule drug product research and development. With several years of experience in analytical research and development for Over-the-Counter (OTC) drug product manufacturers and Contract Development and Manufacturing Organizations (CDMOs), he has developed a strong working knowledge of various drug product formulations and dosage forms. Ian specializes in the development and validation of analytical procedures to support manufacturing, release, and stability testing across all phases of development. He believes that with hard work and a little creativity, any problem can be solved.
Ian VanOeveren's Recent Articles
Navigating Analytical Method Comparability and Equivalency Under ICH Q14: A New Era for Analytical Procedure Lifecycle Management
The landscape of analytical development is continually evolving. With the introduction of ICH Q14: Analytical Procedure Development, the pharmaceutical and biotech sectors now have a formalized framework to guide the creation, validation, and lifecycle management of analytical methods. To keep…